Literature DB >> 9308451

Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database.

R Ballard-Barbash1, S H Taplin, B C Yankaskas, V L Ernster, R D Rosenberg, P A Carney, W E Barlow, B M Geller, K Kerlikowske, B K Edwards, C F Lynch, N Urban, C A Chrvala, C R Key, S P Poplack, J K Worden, L G Kessler.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9308451     DOI： 10.2214/ajr.169.4.9308451

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN： 0361-803X            Impact factor:   3.959


× No keyword cloud information.
  201 in total

1.  Mammography in New Hampshire: characteristics of the women and the exams they receive.

Authors:  P A Carney; M E Goodrich; D M O'Mahony; A N Tosteson; M S Eliassen; S P Poplack; S Birnbaum; B G Harwood; K A Burgess; B T Berube; W S Wells; J P Ball; M M Stevens
Journal:  J Community Health       Date:  2000-06

2.  Radiologists' attitudes and use of mammography audit reports.

Authors:  Joann G Elmore; Erin J Aiello Bowles; Berta Geller; Natalia Vukshich Oster; Patricia A Carney; Diana L Miglioretti; Diana S M Buist; Karla Kerlikowske; Edward A Sickles; Tracy Onega; Robert D Rosenberg; Bonnie C Yankaskas
Journal:  Acad Radiol       Date:  2010-06       Impact factor: 3.173

3.  The impact of obesity on follow-up after an abnormal screening mammogram.

Authors:  Ellen A Schur; Joann E Elmore; Tracy Onega; Karen J Wernli; Edward A Sickles; Sebastien Haneuse
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-12-05       Impact factor: 4.254

4.  Radiologist uncertainty and the interpretation of screening.

Authors:  Patricia A Carney; Joann G Elmore; Linn A Abraham; Martha S Gerrity; R Edward Hendrick; Stephen H Taplin; William E Barlow; Gary R Cutter; Steven P Poplack; Carl J D'Orsi
Journal:  Med Decis Making       Date:  2004 May-Jun       Impact factor: 2.583

5.  Mammographic interpretive volume and diagnostic mammogram interpretation performance in community practice.

Authors:  Sebastien Haneuse; Diana S M Buist; Diana L Miglioretti; Melissa L Anderson; Patricia A Carney; Tracy Onega; Berta M Geller; Karla Kerlikowske; Robert D Rosenberg; Bonnie C Yankaskas; Joann G Elmore; Stephen H Taplin; Robert A Smith; Edward A Sickles
Journal:  Radiology       Date:  2011-11-21       Impact factor: 11.105

6.  Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.

Authors:  Amanda I Phipps; Christopher I Li; Karla Kerlikowske; William E Barlow; Diana S M Buist
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

7.  Utilization of breast cancer screening with magnetic resonance imaging in community practice.

Authors:  Deirdre A Hill; Jennifer S Haas; Robert Wellman; Rebecca A Hubbard; Christoph I Lee; Jennifer Alford-Teaster; Karen J Wernli; Louise M Henderson; Natasha K Stout; Anna N A Tosteson; Karla Kerlikowske; Tracy Onega
Journal:  J Gen Intern Med       Date:  2017-12-06       Impact factor: 5.128

8.  A semiparametric censoring bias model for estimating the cumulative risk of a false-positive screening test under dependent censoring.

Authors:  Rebecca A Hubbard; Diana L Miglioretti
Journal:  Biometrics       Date:  2013-02-05       Impact factor: 2.571

9.  Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?

Authors:  Dejana Braithwaite; Weiwei Zhu; Rebecca A Hubbard; Ellen S O'Meara; Diana L Miglioretti; Berta Geller; Kim Dittus; Dan Moore; Karen J Wernli; Jeanne Mandelblatt; Karla Kerlikowske
Journal:  J Natl Cancer Inst       Date:  2013-02-05       Impact factor: 13.506

10.  Risk factors for inflammatory breast cancer and other invasive breast cancers.

Authors:  Catherine Schairer; Yan Li; Peter Frawley; Barry I Graubard; Robert D Wellman; Diana S M Buist; Karla Kerlikowske; Tracy L Onega; William F Anderson; Diana L Miglioretti
Journal:  J Natl Cancer Inst       Date:  2013-09-18       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.